Examining patient access to investigational drugs :  hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. October 3, 2017. 

 - 1 online resource (iv, 235 pages) :  photographs 
<br/><br/> "Serial No. 115-60."  CRDP Program record. 
<br/><br/>Includes bibliographical references. 
<br/><br/><label>Subjects--Corporate Names: </label><br/>United States. Food and Drug Administration. 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Clinical trials--United States.<br/>Clinical trials--Moral and ethical aspects--United States.<br/>Drugs--Testing.--United States<br/>Drugs--Testing--Moral and ethical aspects--United States.
<br/><br/><label>Index Terms--Genre/Form: </label><br/>Legislative hearings.
<br/><br/><label>LC Class. No.: </label>KF27  / .E553 2017o 
<br/><br/><label>GPO Item No.: </label>1019-C-01 (online) 
<br/><br/><label>Gov. Doc. Class. No.: </label>Y 4.C 73/8:115-60 
<br/><br/><label>Report. No.: </label>Serial no. 115-60 (United States. Congress. House. Committee on Energy and Commerce)